Cleland JG - Search Results

1

Acute heart failure: lessons learned, roads ahead.

Ferrari R, Bueno H, Chioncel O, Cleland JG, Stough WG, Lettino M, Metra M, Parissis JT, Pinto F, Ponikowski P, Ruschitzka F, Tavazzi L. Ferrari R, et al. Among authors: cleland jg. Eur J Heart Fail. 2018 May;20(5):842-850. doi: 10.1002/ejhf.1169. Epub 2018 Mar 8. Eur J Heart Fail. 2018. PMID: 29517124 Free article. Review. No abstract available.

2

The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.

Cleland JG, Gillen G, Dargie HJ. Cleland JG, et al. Eur Heart J. 1988 Feb;9(2):132-41. doi: 10.1093/oxfordjournals.eurheartj.a062466. Eur Heart J. 1988. PMID: 2832173 Review.

3

Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II?

Good JM, Nihoyannopoulos P, Ghatei MA, Crossman D, Bloom SR, Clark P, Oakley CM, Cleland JG. Good JM, et al. Among authors: cleland jg. Eur Heart J. 1994 Dec;15(12):1634-40. doi: 10.1093/oxfordjournals.eurheartj.a060446. Eur Heart J. 1994. PMID: 7698133 Clinical Trial.

4

The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials.

Cleland JG. Cleland JG. Eur Heart J. 1994 Jan;15(1):125-30. doi: 10.1093/oxfordjournals.eurheartj.a060364. Eur Heart J. 1994. PMID: 8174572 Review.

5

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity.

Narang R, Swedberg K, Cleland JG. Narang R, et al. Among authors: cleland jg. Eur Heart J. 1996 Jan;17(1):120-34. doi: 10.1093/oxfordjournals.eurheartj.a014670. Eur Heart J. 1996. PMID: 8682118 Review.

6

Mode of death in chronic heart failure. A request and proposition for more accurate classification.

Narang R, Cleland JG, Erhardt L, Ball SG, Coats AJ, Cowley AJ, Dargie HJ, Hall AS, Hampton JR, Poole-Wilson PA. Narang R, et al. Among authors: cleland jg. Eur Heart J. 1996 Sep;17(9):1390-403. doi: 10.1093/oxfordjournals.eurheartj.a015074. Eur Heart J. 1996. PMID: 8880025 Review.

7

Beta-blocking agents in heart failure. Should they be used and how?

Cleland JG, Bristow MR, Erdmann E, Remme WJ, Swedberg K, Waagstein F. Cleland JG, et al. Eur Heart J. 1996 Nov;17(11):1629-39. doi: 10.1093/oxfordjournals.eurheartj.a014745. Eur Heart J. 1996. PMID: 8922910 Review.

8

Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.

Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG. Cleland JG, et al. Eur Heart J. 1997 Jan;18(1):41-51. Eur Heart J. 1997. PMID: 9049514 Clinical Trial.

9

Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?

McMurray JV, McDonagh TA, Davie AP, Cleland JG, Francis CM, Morrison C. McMurray JV, et al. Among authors: cleland jg. Eur Heart J. 1998 Jun;19(6):842-6. doi: 10.1093/eurheartj/19.6.842. Eur Heart J. 1998. PMID: 9651707 Review.

10

Risk stratification in chronic heart failure.

Cowburn PJ, Cleland JG, Coats AJ, Komajda M. Cowburn PJ, et al. Among authors: cleland jg. Eur Heart J. 1998 May;19(5):696-710. doi: 10.1053/euhj.1997.0820. Eur Heart J. 1998. PMID: 9717002 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,176 results

Search Page

Filters